Volume 9, Number 6—June 2003
Research
Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia1
Table 4
Clinical outcomes
Outcome | Case-patients n=61 (%) | Controls n=87 (%) | p value (unadjusted) | p value (adjusted for severity of illness) |
---|---|---|---|---|
Discharged to home | 13 (22) | 22 (25) | ||
Discharged to an institution | 32 (52) | 42 (48) | 0.83 | 0.67 |
Died during hospitalization | 16 (26) | 23 (26) |
1Presented in part at the 41st Interscience Conference on Antimicrobial Agents and Chemotherapy, Chicago, Illinois, December 2001.